4.7 Article

Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress

期刊

CLINICAL SCIENCE
卷 135, 期 14, 页码 1689-1706

出版社

PORTLAND PRESS LTD
DOI: 10.1042/CS20210198

关键词

-

资金

  1. National Key R&D Program of China [2019YFA0802300, 2018YFC1311505]
  2. National Natural Science Foundation of China [81822005, 81970351, 81941005]
  3. Key Project of Research and Development Plan of Shaanxi Province [2017ZDCXL-SF-02-04-01]

向作者/读者索取更多资源

Recent studies have shown changes in bile acid metabolite composition in metabolic disorders, with glycoursodeoxycholic acid (GUDCA) being decreased in hyperglycemic patients. GUDCA supplementation alleviated ER stress and apoptosis, stabilizing calcium homeostasis, and ameliorated insulin resistance and hepatic steatosis in HFD-fed mice. This suggests that GUDCA may be a potential treatment option for metabolic disorders by inhibiting ER stress.
Recent studies reveal that bile acid metabolite composition and its metabolism are changed in metabolic disorders, such as obesity, type 2 diabetes and metabolic associated fatty liver disease (MAFLD), yet its role and the mechanism remain largely unknown. In the present study, metabolomic analysis of 163 serum and stool samples of our metabolic disease cohort was performed, and we identified glycoursodeoxycholic acid (GUDCA), glycine-conjugated bile acid produced from intestinal bacteria, was decreased in both serum and stool samples from patients with hyperglycemia. RNA-sequencing and quantitative PCR results indicated that GUDCA alleviated endoplasmic reticulum (ER) stress in livers of high fat diet (HFD)-fed mice without alteration of liver metabolism. In vitro, GUDCA reduced palmitic acid induced-ER stress and -apoptosis, as well as stabilized calcium homeostasis. In vivo, GUDCA exerted effects on amelioration of HFD-induced insulin resistance and hepatic steatosis. In parallel, ER stress and apoptosis were decreased in GUDCA-treated mice as compared with vehicle-treated mice in liver. These findings demonstrate that reduced GUDCA is an indicator of hyperglycemia. Supplementation of GUDCA could be an option for the treatment of diet-induced metabolic disorders, including insulin resistance and hepatic steatosis, with inhibiting ER stress.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据